Table of Contents

2019-2024 Global Emerging Cancer Diagnostics Market Report (Status and Outlook)

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Emerging Cancer Diagnostics Market Size 2014-2024
2.1.2 Emerging Cancer Diagnostics Market Size CAGR by Region
2.2 Emerging Cancer Diagnostics Segment by Type
2.2.1 Men
2.2.2 Women
2.3 Emerging Cancer Diagnostics Market Size by Type
2.3.1 Global Emerging Cancer Diagnostics Market Size Market Share by Type (2014-2019)
2.3.2 Global Emerging Cancer Diagnostics Market Size Growth Rate by Type (2014-2019)
2.4 Emerging Cancer Diagnostics Segment by Application
2.4.1 Blood Cancer
2.4.2 Prostate Cancer
2.4.3 Breast Cancer
2.4.4 Lung Cancer
2.4.5 Others
2.5 Emerging Cancer Diagnostics Market Size by Application
2.5.1 Global Emerging Cancer Diagnostics Market Size Market Share by Application (2014-2019)
2.5.2 Global Emerging Cancer Diagnostics Market Size Growth Rate by Application (2014-2019)

3 Global Emerging Cancer Diagnostics by Players
3.1 Global Emerging Cancer Diagnostics Market Size Market Share by Players
3.1.1 Global Emerging Cancer Diagnostics Market Size by Players (2017-2019)
3.1.2 Global Emerging Cancer Diagnostics Market Size Market Share by Players (2017-2019)
3.2 Global Emerging Cancer Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers and Acquisitions, Expansion

4 Emerging Cancer Diagnostics by Regions
4.1 Emerging Cancer Diagnostics Market Size by Regions
4.2 Americas Emerging Cancer Diagnostics Market Size Growth
4.3 APAC Emerging Cancer Diagnostics Market Size Growth
4.4 Europe Emerging Cancer Diagnostics Market Size Growth
4.5 Middle East and Africa Emerging Cancer Diagnostics Market Size Growth

5 Americas
5.1 Americas Emerging Cancer Diagnostics Market Size by Countries
5.2 Americas Emerging Cancer Diagnostics Market Size by Type
5.3 Americas Emerging Cancer Diagnostics Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Emerging Cancer Diagnostics Market Size by Countries
6.2 APAC Emerging Cancer Diagnostics Market Size by Type
6.3 APAC Emerging Cancer Diagnostics Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Emerging Cancer Diagnostics by Countries
7.2 Europe Emerging Cancer Diagnostics Market Size by Type
7.3 Europe Emerging Cancer Diagnostics Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East and Africa
8.1 Middle East and Africa Emerging Cancer Diagnostics by Countries
8.2 Middle East and Africa Emerging Cancer Diagnostics Market Size by Type
8.3 Middle East and Africa Emerging Cancer Diagnostics Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Emerging Cancer Diagnostics Market Forecast
10.1 Global Emerging Cancer Diagnostics Market Size Forecast (2019-2024)
10.2 Global Emerging Cancer Diagnostics Forecast by Regions
10.2.1 Global Emerging Cancer Diagnostics Forecast by Regions (2019-2024)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East and Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East and Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Emerging Cancer Diagnostics Forecast by Type
10.8 Global Emerging Cancer Diagnostics Forecast by Application

11 Key Players Analysis
11.1 Abbott Laboratories
11.1.1 Company Details
11.1.2 Emerging Cancer Diagnostics Product Offered
11.1.3 Abbott Laboratories Emerging Cancer Diagnostics Revenue, Gross Margin and Market Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 Abbott Laboratories News
11.2 Danaher
11.2.1 Company Details
11.2.2 Emerging Cancer Diagnostics Product Offered
11.2.3 Danaher Emerging Cancer Diagnostics Revenue, Gross Margin and Market Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 Danaher News
11.3 Agilent Technologies
11.3.1 Company Details
11.3.2 Emerging Cancer Diagnostics Product Offered
11.3.3 Agilent Technologies Emerging Cancer Diagnostics Revenue, Gross Margin and Market Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 Agilent Technologies News
11.4 AstraZeneca
11.4.1 Company Details
11.4.2 Emerging Cancer Diagnostics Product Offered
11.4.3 AstraZeneca Emerging Cancer Diagnostics Revenue, Gross Margin and Market Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 AstraZeneca News
11.5 BD
11.5.1 Company Details
11.5.2 Emerging Cancer Diagnostics Product Offered
11.5.3 BD Emerging Cancer Diagnostics Revenue, Gross Margin and Market Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 BD News
11.6 Biocept
11.6.1 Company Details
11.6.2 Emerging Cancer Diagnostics Product Offered
11.6.3 Biocept Emerging Cancer Diagnostics Revenue, Gross Margin and Market Share (2017-2019)
11.6.4 Main Business Overview
11.6.5 Biocept News
11.7 Illumina
11.7.1 Company Details
11.7.2 Emerging Cancer Diagnostics Product Offered
11.7.3 Illumina Emerging Cancer Diagnostics Revenue, Gross Margin and Market Share (2017-2019)
11.7.4 Main Business Overview
11.7.5 Illumina News
11.8 Luminex
11.8.1 Company Details
11.8.2 Emerging Cancer Diagnostics Product Offered
11.8.3 Luminex Emerging Cancer Diagnostics Revenue, Gross Margin and Market Share (2017-2019)
11.8.4 Main Business Overview
11.8.5 Luminex News
11.9 NeoGenomics
11.9.1 Company Details
11.9.2 Emerging Cancer Diagnostics Product Offered
11.9.3 NeoGenomics Emerging Cancer Diagnostics Revenue, Gross Margin and Market Share (2017-2019)
11.9.4 Main Business Overview
11.9.5 NeoGenomics News
11.10 QIAGEN
11.10.1 Company Details
11.10.2 Emerging Cancer Diagnostics Product Offered
11.10.3 QIAGEN Emerging Cancer Diagnostics Revenue, Gross Margin and Market Share (2017-2019)
11.10.4 Main Business Overview
11.10.5 QIAGEN News
11.11 Thermo Fisher Scientific

12 Research Findings and Conclusion